Further studies are needed to clarify the relationship between serum nesfatin-1 levels and obesity and whether targeted nesfatin-1 drug therapy can be used as a method of decreasing weight in obese individuals. Here, NUCB2 is linked to obesity due to melanocortin 4 receptor deficiency.